tradingkey.logo


tradingkey.logo


Bone Biologics Corp

BBLG
1.110USD
-0.005-0.43%
取匕時間 ET15分遅れの株䟡
2.02K時䟡総額
損倱額盎近12ヶ月PER


Bone Biologics Corp

1.110
-0.005-0.43%

詳现情報 Bone Biologics Corp 䌁業名

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corpの䌁業情報


䌁業コヌドBBLG
䌚瀟名Bone Biologics Corp
䞊堎日Nov 27, 2015
最高経営責任者「CEO」Frelick (Jeffrey)
埓業員数2
蚌刞皮類Ordinary Share
決算期末Nov 27
本瀟所圚地2 Burlington Woods Dr Ste 100
郜垂BURLINGTON
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号01803-4551
電話番号17815524452
りェブサむトhttps://www.bonebiologics.com/
䌁業コヌドBBLG
䞊堎日Nov 27, 2015
最高経営責任者「CEO」Frelick (Jeffrey)

Bone Biologics Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
DRW Securities, LLC
1.31%
Two Sigma Investments, LP
0.62%
Citadel Advisors LLC
0.60%
Geode Capital Management, L.L.C.
0.35%
Tower Research Capital LLC
0.19%
他の
96.93%
株䞻統蚈
株䞻統蚈
比率
DRW Securities, LLC
1.31%
Two Sigma Investments, LP
0.62%
Citadel Advisors LLC
0.60%
Geode Capital Management, L.L.C.
0.35%
Tower Research Capital LLC
0.19%
他の
96.93%
皮類
株䞻統蚈
比率
Investment Advisor
1.42%
Hedge Fund
1.41%
Investment Advisor/Hedge Fund
0.35%
Individual Investor
0.04%
Research Firm
0.02%
他の
96.76%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
15
13.28K
0.99%
--
2025Q3
23
14.93K
1.62%
+12.83K
2025Q2
23
2.10K
1.96%
-3.89K
2025Q1
23
5.99K
6.22%
-27.92K
2024Q4
25
11.69K
8.76%
-6.90K
2024Q3
24
17.54K
8.58%
+4.95K
2024Q2
23
11.22K
11.00%
+2.60K
2024Q1
23
8.62K
9.21%
-4.88K
2023Q4
22
1.85K
15.09%
-9.81K
2023Q3
21
11.67K
14.02%
-1.55K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
DRW Securities, LLC
11.03K
0.61%
+11.03K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
--
0%
-4.03K
-100.00%
Jun 30, 2025
Tower Research Capital LLC
1.46K
0.08%
+1.26K
+632.00%
Sep 30, 2025
UBS Financial Services, Inc.
66.00
0%
-47.00
-41.59%
Sep 30, 2025
Frelick (Jeffrey)
359.00
0.02%
+3.00
+0.84%
Apr 11, 2025
Walsh (Deina H)
313.00
0.02%
--
--
Apr 11, 2025
SBI Securities Co., Ltd.
230.00
0.01%
+230.00
--
Sep 30, 2025
Clear Street LLC
138.00
0.01%
+138.00
--
Jun 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
日付
配圓萜ち日
皮類
比率
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
KeyAI
î™